Back in 2019 I wrote a couple of posts summarizing what we had learned from research about peer review at journals. Since…

This month, Arcturus’ self-amplifying mRNA vaccine was approved for use in the UK. There were also new clinical trial results for another…

This month, the first clinical trial for a pancoronavirus formulation of an existing Covid vaccine was registered. Although it’s just on the…

I hadn’t been aware of the term science populism until a video about it did the rounds recently. It was a light-bulb…

Last month’s update ran long, so this one covers less than a month – but there’s still a lot of news. There…

We’ve had to wait a long time to get to this point. If cervical cancer develops after HPV infection, it will take…

This was always going to be a big month, with results from clinical trials of 2 vaccines, as well as 3 new…

The Mastodon migration from Twitter in 2022 was massive for the non-commercial community network: The number of accounts swelled with more than…

It was a bumper month for mucosal Covid vaccines. There were some phase 1 results for an intranasal vaccine from China: It’s…

Wikipedia is, “without exaggeration, the digital world’s factual foundation,” wrote Josh Dzieza recently. It’s a target because of that, squarely in the…

This month, there was unexpected Project NextGen news: A new phase 1 clinical trial started, for an exosome vaccine. There was also…

With the US federal workforce, equity and inclusiveness, and government statistics all under assault, it’s timely to consider the effort it took…